Autopsy report · NCT00058773
Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease
Cause of deathNo reason given
Life of this trial
- Registered 7 years 3 months after it had already started.
- Ran for about 10 years 7 months before it stopped.
- 5 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Baylor College of Medicine
- Sponsor type
- University, hospital or other
- Conditions
- Hodgkin Disease; Non-Hodgkins Lymphoma
- Interventions
- Infusion of EBV Specific Cytotoxic T-Lymphocytes
- Participants
- 5
- Sites
- 2
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.